Related Experiment Videos
[Risk stratification in acute coronary syndrome]
1Universitätskrankenhaus Hamburg-Eppendorf. goldmann@uke.uni-hamburg.de
Herz
|May 15, 2001
Summary
Troponin T or I measurements reliably detect minor myocardial damage, aiding risk stratification for acute coronary syndromes. Elevated troponins indicate high cardiac risk, necessitating prompt hospitalization and treatment.
Area of Science:
- Cardiology
- Biomarker Analysis
Background:
- Active ischemic heart disease presents a spectrum of symptoms, from silent ischemia to acute myocardial infarction.
- Evaluating patients with non-ST-elevation acute coronary syndromes is challenging due to limitations of clinical symptoms, ECG, and CK-MB for risk stratification.
Purpose of the Study:
- To highlight the utility of troponin measurements in risk stratification for acute coronary syndromes.
- To emphasize the importance of early detection of myocardial damage for therapeutic decision-making.
Main Methods:
- Serial measurements of troponin T or troponin I were utilized.
- Risk stratification was performed based on troponin levels and clinical presentation.
Main Results:
- Serial troponin measurements reliably detect minor myocardial damage, identifying high-risk patients.
- Patients with elevated troponins face cardiac event risks comparable to those with acute myocardial infarction.
- Absence of troponin elevation indicates a cardiac risk of less than 1% for death or myocardial infarction.
Conclusions:
- Patients with elevated troponins require early hospitalization and evaluation for timely, effective therapy.
- This high-risk subgroup, often presenting as unstable angina, may benefit from antithrombotic treatments and revascularization strategies.